SVB Securities Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Securities. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Securities. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Europe Australia Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsCTICCTI BioPharma5/16/2023Downgraded bySVB SecuritiesOutperform -> Market PerformLowARWRArrowhead Pharmaceuticals5/12/2023Downgraded bySVB SecuritiesOutperform -> Market Perform $40.00LowTRHCTabula Rasa HealthCare5/10/2023Upgraded bySVB SecuritiesMarket Perform -> Outperform$7.00 -> $10.00LowVIRVir Biotechnology5/5/2023Target Lowered bySVB Securities$43.00 -> $42.00LowREGNRegeneron Pharmaceuticals5/5/2023Target Lowered bySVB Securities$976.00 -> $895.00LowPRVAPrivia Health Group5/5/2023Target Raised bySVB Securities$39.00 -> $40.00LowLNTHLantheus5/5/2023Target Raised bySVB Securities$120.00 -> $127.00LowAMEDAmedisys5/5/2023Target Lowered bySVB Securities$96.00 -> $81.00LowALHCAlignment Healthcare5/5/2023Target Lowered bySVB Securities$24.00 -> $12.00LowAGIOAgios Pharmaceuticals5/5/2023Target Lowered bySVB Securities$37.00 -> $34.00LowABCLAbCellera Biologics5/5/2023Target Lowered bySVB Securities$16.00 -> $15.00LowLLYEli Lilly and5/1/2023Target Raised bySVB Securities$410.00 -> $458.00LowDHRDanaher5/1/2023Initiated bySVB SecuritiesOutperform $300.00LowHUMHumana4/27/2023Target Lowered bySVB Securities$640.00 -> $600.00LowALVRAlloVir4/26/2023Target Raised bySVB Securities$16.00 -> $19.00LowPRTAProthena4/24/2023Initiated bySVB SecuritiesOutperform $80.00LowMRUSMerus4/17/2023Target Raised bySVB SecuritiesOutperform$35.00 -> $48.00LowFDMT4D Molecular Therapeutics4/13/2023Target Lowered bySVB SecuritiesMarket Perform$14.00 -> $13.00LowBBIOBridgeBio Pharma4/13/2023Target Raised bySVB SecuritiesOutperform$25.00 -> $27.00LowARWRArrowhead Pharmaceuticals4/12/2023Upgraded bySVB SecuritiesMarket Perform -> Outperform$21.00 -> $35.00LowCORTCorcept Therapeutics4/11/2023Initiated bySVB SecuritiesMarket Perform $25.00LowIPHAInnate Pharma4/10/2023Target Raised bySVB Securities$9.00 -> $10.00LowPRDSPardes Biosciences4/4/2023Downgraded bySVB SecuritiesOutperform -> Market PerformLowACLXArcellx3/30/2023Target Raised bySVB Securities$35.00 -> $39.00LowREGNRegeneron Pharmaceuticals3/27/2023Upgraded bySVB SecuritiesMarket Perform -> Outperform$834.00 -> $976.00LowINCYIncyte3/24/2023Upgraded bySVB SecuritiesUnderperform -> Market Perform $61.00LowRAINRain Oncology3/21/2023Initiated bySVB SecuritiesOutperform $11.00LowPTCTPTC Therapeutics3/17/2023Initiated bySVB SecuritiesMarket Perform $48.00LowCNTACentessa Pharmaceuticals3/17/2023Initiated bySVB SecuritiesOutperform $6.00LowHALOHalozyme Therapeutics3/16/2023Downgraded bySVB SecuritiesOutperform -> Market Perform $42.00LowDBTXDecibel Therapeutics3/15/2023Downgraded bySVB SecuritiesOutperform -> Market Perform$7.00 -> $2.00LowSGENSeagen3/14/2023Target Raised bySVB Securities$141.00 -> $229.00LowFULCFulcrum Therapeutics3/10/2023Target Lowered bySVB Securities$18.00 -> $10.00LowMORFMorphic3/8/2023Target Raised bySVB Securities$45.00 -> $56.00LowICPTIntercept Pharmaceuticals3/3/2023Target Raised bySVB Securities$17.00 -> $18.00LowARGXargenx3/3/2023Target Raised bySVB Securities$430.00 -> $435.00LowAHCOAdaptHealth3/1/2023Target Lowered bySVB Securities$30.00 -> $23.00LowMDRXVeradigm3/1/2023Target Lowered bySVB Securities$24.00 -> $17.00LowRETAReata Pharmaceuticals3/1/2023Target Raised bySVB Securities$35.00 -> $75.00N/AGPCRStructure Therapeutics2/28/2023Initiated bySVB SecuritiesOutperform $33.00LowIRONDisc Medicine Opco2/28/2023Initiated bySVB SecuritiesOutperform $36.00LowNKTRNektar Therapeutics2/24/2023Target Lowered bySVB Securities$5.00 -> $3.00N/ABPMCBlueprint Medicines2/24/2023Target Lowered bySVB Securities$45.00 -> $38.00LowMRNAModerna2/24/2023Downgraded bySVB SecuritiesMarket Perform -> Underperform$111.00 -> $93.00LowIONSIonis Pharmaceuticals2/23/2023Target Lowered bySVB Securities$34.00 -> $27.00LowTDOCTeladoc Health2/23/2023Upgraded bySVB SecuritiesMarket Perform -> Outperform $34.00LowABBVAbbVie2/10/2023Upgraded bySVB SecuritiesUnderperform -> Market Perform$135.00 -> $153.00LowVRTXVertex Pharmaceuticals2/8/2023Target Lowered bySVB Securities$374.00 -> $365.00LowCIThe Cigna Group2/8/2023Target Lowered bySVB Securities$335.00 -> $309.00LowSGENSeagen2/6/2023Downgraded bySVB SecuritiesOutperform -> Market Perform$162.00 -> $141.00LowMETAMeta Platforms2/2/2023Target Raised bySVB SecuritiesOutperform$220.00 -> $255.00LowAMGNAmgen2/2/2023Target Lowered bySVB Securities$282.00 -> $267.00LowDNLIDenali Therapeutics1/30/2023Initiated bySVB SecuritiesOutperform $50.00LowBHVNBiohaven1/24/2023Initiated bySVB SecuritiesOutperform $24.00Low MarketBeat Community Rating for SVB SecuritiesCommunity Ranking: 2.4 out of 5 (2.4 of 5 stars)Outperform Votes: 2,291 (Vote Outperform)Underperform Votes: 2,526 (Vote Underperform)Total Votes: 4,817MarketBeat's community ratings are surveys of what our community members think about SVB Securities and other research firms. Vote "Outperform" if you believe SVB Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings European Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.